[1] |
LEI Kunyang, XIE Wenjie, SUN Ting, LIU Yifu, WANG Xu.
Expression and effect of long non-coding RNA ARAP1-AS1 in clear cell renal cell carcinoma
[J]. China Oncology, 2022, 32(1): 34-40.
|
[2] |
XU Wenhao, TIAN Xi, Aihetaimujiang·Anwaier , QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
A systematic review of current advancements of artificial intelligence in genitourinary cancers
[J]. China Oncology, 2022, 32(1): 68-74.
|
[3] |
YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun.
Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk
[J]. China Oncology, 2021, 31(9): 828-837.
|
[4] |
LUO Rong , HU Peian , XIE Tiansong , ZHANG Zehua , ZHOU Liangping , ZHOU Zhengrong , CHEN Lei .
The correlation of imaging, clinical features and pathology of myxoid fibrosarcoma
[J]. China Oncology, 2021, 31(8): 734-739.
|
[5] |
HU Guannan , CHEN Lei , ZHOU Liangping , ZHOU Zhengrong .
A case report of pulmonary malignant melanoma complicated with lung adenocarcinoma and literature review
[J]. China Oncology, 2021, 31(7): 647-650.
|
[6] |
YIN Zhihai, WANG Juanqi, MENG Yiran, XU Qing, YANG Zhaozhi.
Investigation of patient characteristics associated with setup errors in intensity-modulated radiotherapy after breast-conserving surgery
[J]. China Oncology, 2021, 31(3): 198-202.
|
[7] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
[8] |
WANG Jia , AI Zhongzhong , ZHOU Jing .
Effects of SLC6A3 downregulation on proliferation and migration of SNU-349 cells in renal clear cell carcinoma
[J]. China Oncology, 2021, 31(1): 20-26.
|
[9] |
TONG Ying, YU Yiwen, XIE Suhong, WANG Yanchun, LU Renquan, GUO Lin.
Effects of silent information regulator 4 overexpression or glutamine deprivation on apoptosis and proliferation of clear cell renal cell carcinoma
[J]. China Oncology, 2020, 30(6): 435-440.
|
[10] |
REN Caiyue, WANG Shengping, ZHANG Shengjian, PENG Weijun.
The value of MSCT signs combined with texture analysis in preoperatively predicting WHO simplified pathological classification of thymic epithelial tumors
[J]. China Oncology, 2020, 30(6): 468-474.
|
[11] |
WU Ziyi, WANG Yan, MENG Yiran, XU Qing.
Comparison of the application of cone-beam CT and Catalyst TM system in image-guided radiotherapy
[J]. China Oncology, 2020, 30(12): 1031-1034.
|
[12] |
ZHOU Yaodong , CHEN Zongwei , CHEN Haiquan .
Lung cancer screening strategy for non-high-risk population
[J]. China Oncology, 2020, 30(10): 726-732.
|
[13] |
TIAN Xi, XU Wenhao, QU Yuanyuan, WANG Jun, WANG Hongkai, CAO Dalong, SHI Guohai, ZHANG Hailiang, YE Dingwei.
Clinical features of renal cell carcinoma carrying second primary estrogen-related tumors: propensity score matching analysis
[J]. China Oncology, 2019, 29(12): 941-947.
|
[14] |
XU Mingbin, ZHAO Yutong, LI Chengyang, ZHAO Jiawen, MA Chenjun, LIAO Naikai, YANG Zhanbin, CHENG Jiwen.
Predictive value of lymphocyte-to-monocyte ratio and serum albumin in patients with clear cell renal cell carcinoma
[J]. China Oncology, 2019, 29(11): 887-898.
|
[15] |
LU Jie, CHANG Bin, WANG Wei.
CT manifestations of renal oncocytoma
[J]. China Oncology, 2018, 28(7): 511-514.
|